Viyash Scientific Limited (SEQUENT) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.051x

Based on the latest financial reports, Viyash Scientific Limited (SEQUENT) has a cash flow conversion efficiency ratio of 0.051x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs449.00 Million ≈ $4.86 Million USD) by net assets (Rs8.87 Billion ≈ $95.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Viyash Scientific Limited's balance sheet to measure how much of total assets are equity-financed.

Viyash Scientific Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Viyash Scientific Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Viyash Scientific Limited (SEQUENT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Viyash Scientific Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Viyash Scientific Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Galiano Gold Inc
TO:GAU
0.178x
Surfilter Network Technology Co Ltd
SHE:300311
0.007x
Riskified Ltd
NYSE:RSKD
0.035x
Nouveau Monde Graphite Inc
NYSE:NMG
-0.133x
Cub Elecparts Inc
TW:2231
0.005x
Pagerduty Inc
NYSE:PD
0.094x
Ningbo Color Master Batch Co. Ltd.
SHE:301019
0.030x
Sinon Corp
TW:1712
0.127x

Annual Cash Flow Conversion Efficiency for Viyash Scientific Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Viyash Scientific Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Viyash Scientific Limited (SEQUENT) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs7.70 Billion
≈ $83.31 Million
Rs833.60 Million
≈ $9.02 Million
0.108x +152.16%
2024-03-31 Rs7.13 Billion
≈ $77.10 Million
Rs305.95 Million
≈ $3.31 Million
0.043x +91.28%
2023-03-31 Rs7.49 Billion
≈ $81.02 Million
Rs168.08 Million
≈ $1.82 Million
0.022x -45.73%
2022-03-31 Rs7.40 Billion
≈ $80.04 Million
Rs305.95 Million
≈ $3.31 Million
0.041x -72.03%
2021-03-31 Rs7.76 Billion
≈ $83.96 Million
Rs1.15 Billion
≈ $12.41 Million
0.148x -6.20%
2020-03-31 Rs7.32 Billion
≈ $79.15 Million
Rs1.15 Billion
≈ $12.47 Million
0.158x +1.45%
2019-03-31 Rs7.47 Billion
≈ $80.78 Million
Rs1.16 Billion
≈ $12.55 Million
0.155x +135.05%
2018-03-31 Rs6.85 Billion
≈ $74.03 Million
Rs452.39 Million
≈ $4.89 Million
0.066x +1013.61%
2017-03-31 Rs9.94 Billion
≈ $107.50 Million
Rs-71.90 Million
≈ $-777.57K
-0.007x -12597.48%
2016-03-31 Rs9.48 Billion
≈ $102.51 Million
Rs-540.00K
≈ $-5.84K
0.000x +99.94%
2015-03-31 Rs2.38 Billion
≈ $25.76 Million
Rs-235.49 Million
≈ $-2.55 Million
-0.099x +86.47%
2014-03-31 Rs613.06 Million
≈ $6.63 Million
Rs-447.85 Million
≈ $-4.84 Million
-0.731x -1803.87%
2013-03-31 Rs995.83 Million
≈ $10.77 Million
Rs-38.21 Million
≈ $-413.23K
-0.038x -116.25%
2012-03-31 Rs1.28 Billion
≈ $13.84 Million
Rs302.36 Million
≈ $3.27 Million
0.236x -37.08%
2011-03-31 Rs1.35 Billion
≈ $14.60 Million
Rs506.60 Million
≈ $5.48 Million
0.375x +148.36%
2010-03-31 Rs1.12 Billion
≈ $12.09 Million
Rs168.95 Million
≈ $1.83 Million
0.151x +223.00%
2009-03-31 Rs405.20 Million
≈ $4.38 Million
Rs-49.79 Million
≈ $-538.46K
-0.123x -14561.60%
2008-03-31 Rs573.71 Million
≈ $6.20 Million
Rs487.47K
≈ $5.27K
0.001x -99.26%
2007-03-31 Rs349.24 Million
≈ $3.78 Million
Rs40.21 Million
≈ $434.91K
0.115x -68.51%
2006-03-31 Rs198.08 Million
≈ $2.14 Million
Rs72.43 Million
≈ $783.26K
0.366x --

About Viyash Scientific Limited

NSE:SEQUENT India Drug Manufacturers - Specialty & Generic
Market Cap
$529.07 Million
Rs48.92 Billion INR
Market Cap Rank
#11999 Global
#594 in India
Share Price
Rs193.72
Change (1 day)
-3.70%
52-Week Range
Rs168.04 - Rs252.00
All Time High
Rs322.89
About

Viyash Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was former… Read more